Articles Tagged With:
-
Clinical Briefs by Louis Kuritzky, MD
-
Sipuleucel-T Suspension for Intravenous Infusion (Provenge®
The first immunotherapy has been approved by the FDA for the treatment of hormone-resistant prostate cancer. -
Osteoporosis Treatment After Hip Fracture: Missed Opportunities
After hip fracture due to osteoporosis, only 2% of patients had ideal treatment initiated in the hospital with antiresorptive or bone-forming medications combined with calcium and vitamin D -
Monofilament Testing for Diabetic Peripheral Neuropathy
Despite guideline recommendations to utilize monofilaments to detect diabetic peripheral neuropathy, there is a paucity of published literature to support its accuracy. -
Internal Medicine Alert - Full June 15, 2010 Issue in PDF
-
ECG Review: RBBB Plus?
The ECG shown above was obtained from a 47-year-old woman with atypical chest pain. Is there more going on in this tracing than just the conduction defect? -
PPI Use and Fracture Risk
Women who used proton pump inhibitors had a modestly increased risk of spine, forearm or wrist, and total fractures, but not hip fractures. -
Clinical Briefs by Louis Kuritzky, MD
In the absence of contraindications, metformin is the preferred initial treatment for most patients with type 2 diabetes (DM2). Unfortunately, monotherapy is unlikely to maintain adequate glycemic control, requiring additional treatment. -
Naproxen and Esomeprazole Delayed-Release Tablets (Vimovo®)
-
To Drive or Not to Drive? That Is the Question
Patients with dementia and their physicians face the difficult decision to cease driving with little solid evidence to guide them.